二尖瓣手术同期行心房颤动手术的长期结果:一项倾向性评分匹配的多中心研究
该多中心倾向性评分匹配研究纳入2005至2017年5中心2680例心房颤动合并二尖瓣疾病行二尖瓣手术患者,匹配后1442例分为心房颤动手术组与非心房颤动手术组各721例。心房颤动手术组全因生存率、心脏死亡无生存率更高,再次手术、主要不良心脑血管事件及卒中或短暂性脑缺血发作累积发生率更低,但永久起搏器植入累积发生率更高。
要点
- 心房颤动手术组5年与10年总体生存率分别为91.0%与80.7%,非心房颤动手术组为86.5%与75.9%(P = .013)。
- 心房颤动手术组主要不良心脑血管事件及卒中或短暂性脑缺血发作累积发生率更低(P < .001与P = .012)。
- 心房颤动手术组永久起搏器植入累积发生率高于非心房颤动手术组(P < .001)。
核心结论
- 在心房颤动合并二尖瓣疾病患者中,二尖瓣手术同期行心房颤动手术与术后15年内更低的死亡率、心脏死亡率、主要不良心脑血管事件及卒中或短暂性脑缺血发作相关。
研究设计与样本
- 多中心倾向性评分匹配研究,纳入2005至2017年5个中心2680例心房颤动合并二尖瓣疾病行二尖瓣手术患者(心房颤动手术组n = 1841,非心房颤动手术组n = 839),匹配后提取1442例(心房颤动手术组n = 721,非心房颤动手术组n = 721)。
主要发现
- 匹配后心房颤动手术组5年与10年总体生存率分别为91.0%与80.7%,非心房颤动手术组分别为86.5%与75.9%(P = .013)。
- 匹配后心房颤动手术组5年与10年心脏死亡无生存率分别为96.9%与91.7%,非心房颤动手术组分别为90.9%与83.7%(P < .001)。
- 匹配后心房颤动手术组再次手术、主要不良心脑血管事件及卒中或短暂性脑缺血发作的累积发生率在术后15年内均低于非心房颤动手术组(P = .010、P < .001、P = .012)。
- 匹配后心房颤动手术组永久起搏器植入累积发生率高于非心房颤动手术组(P < .001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of the study was to elucidate the long-term outcomes of atrial fibrillation surgery in patients with atrial fibrillation and mitral valve disease by comparing the patients who underwent mitral valve surgery with and without atrial fibrillation surgery. METHODS: Between 2005 and 2017, 2680 patients with atrial fibrillation who underwent mitral valve surgery (mitral valve surgery with atrial fibrillation surgery, n = 1841; mitral valve surgery without atrial fibrillation surgery, n = 839) at 5 centers were included. After propensity score matching, 1442 patients were extracted (atrial fibrillation surgery group, n = 721; non-atrial fibrillation surgery group, n = 721). All-cause mortality, cardiac mortality, major adverse cardiac and cerebrovascular events, stroke or transient ischemic attack, and permanent pacemaker implantation were compared between the atrial fibrillation surgery and non-atrial fibrillation surgery groups. RESULTS: Overall survivals at 5 and 10 years postoperatively were 91.0% and 80.7% in the atrial fibrillation surgery group and 86.5% and 75.9% in the non-atrial fibrillation surgery group, respectively (P = .013). Cardiac mortality-free survivals at 5 and 10 years postoperatively were 96.9% and 91.7% in the atrial fibrillation surgery group and 90.9% and 83.7% in the non-atrial fibrillation surgery group, respectively (P < .001). Cumulative incidence of reoperation, major adverse cardiac and cerebrovascular events, and stroke or transient ischemic attack was lower in the matched atrial fibrillation surgery group compared with the matched non-atrial fibrillation surgery group up to 15 years postoperatively (P = .010, P < .001, and P = .012, respectively). Cumulative incidence of permanent pacemaker implantation was higher in the matched atrial fibrillation surgery group compared with the matched non-atrial fibrillation surgery group (P < .001). CONCLUSIONS: In patients with atrial fibrillation and mitral valve disease, mitral valve surgery concomitant with atrial fibrillation surgery was associated with lower mortality, cardiac mortality, major adverse cardiac and cerebrovascular events, and stroke or transient ischemic attack up to 15 years after surgery when compared with mitral valve surgery without atrial fibrillation surgery.
引用
- Kim MS, Kim HJ, Je HG, et al. Long-term results of atrial fibrillation surgery concomitant with mitral valve surgery: A propensity score-matched multicenter study. J Thorac Cardiovasc Surg. 2024. PMID: 38237763. doi:10.1016/j.jtcvs.2024.01.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。